mhurhangee/ep-ind-claims huggingface dataset:
A rubber composition, comprising a rubber component and a filler, wherein the rubber component contains a conjugated diene-based polymer modified with a modifier containing a compound represented by the formula where R1 to R8 are each an independent alkyl group having 1 to 20 carbon atoms; L1 and L2 are each an independent alkylene group having 1 to 20 carbon atoms; and n is an integer of 2 to 4.
A surgical stapling apparatus (100, 200), comprising: a housing having an actuator; an elongated member extending from the housing; an end effector disposed on an end of the elongated member, the end effector having a first jaw and a second jaw, the first jaw having a staple cartridge and the second jaw having a plurality of staple forming recesses; the staple cartridge having a plurality of individual separately movable segments extending axially along a length of the staple cartridge, each segment having a tissue contacting surface and staple receiving slots defined in the tissue contacting surface,; a biasing member for each of the segments biasing the segments toward the second jaw; and each of the segments has a pressure sensor for sensing a force that is exerted on each segment during approximation of the first and second jaws and/or during firing of the end effector.. a housing having an actuator; an elongated member extending from the housing; an end effector disposed on an end of the elongated member, the end effector having a first jaw and a second jaw, the first jaw having a staple cartridge and the second jaw having a plurality of staple forming recesses; the staple cartridge having a plurality of individual separately movable segments extending axially along a length of the staple cartridge, each segment having a tissue contacting surface and staple receiving slots defined in the tissue contacting surface,; a biasing member for each of the segments biasing the segments toward the second jaw; and each of the segments has a pressure sensor for sensing a force that is exerted on each segment during approximation of the first and second jaws and/or during firing of the end effector..
A process for removing metal contaminants from a contaminated fluid stream comprising the step of contacting said fluid stream with macroporous alpha alumina to obtain a fluid stream containing less than 50 ppm of metal, wherein said fluid stream is a stream of mineral acid(s).
A cyclic amine derivative represented by the following general formula: wherein R 1 represents an alkyloxy group having 1 to 3 carbon atoms, any 1 to 3 hydrogen atoms of which are optionally substituted with a halogen atom(s); R 2 represents a halogen atom; R 3 represents a hydrogen atom, a halogen atom, or a hydroxy group; R 4 represents a hydrogen atom or a halogen atom; X represents -C(=O)-(CH 2) n -R 5 or -S(=O) 2 -R 6; n is an integer of 0 to 5; R 5 represents a hydrogen atom, -OR 7, -SR 7, -S(=O) 2 -R 7, -C(=O)-OR 7, -N(R 7)R 8, an alkyl group having 1 to 3 carbon atoms, any 1 to 3 hydrogen atoms of which are optionally substituted with a halogen atom(s), or a heteroaryl group, any hydrogen atom(s) of which is/are optionally substituted with an alkyl group(s) having 1 to 3 carbon atoms; R 6 represents an alkyl group having 1 to 5 carbon atoms; R 7 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, any 1 to 3 hydrogen atoms of which are optionally substituted with a halogen atom(s); and R 8 represents a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, an acyl group having 2 to 4 carbon atoms, or an alkylsulfonyl group having 1 to 3 carbon atoms, or a pharmacologically acceptable salt thereof. R 1 represents an alkyloxy group having 1 to 3 carbon atoms, any 1 to 3 hydrogen atoms of which are optionally substituted with a halogen atom(s); R 2 represents a halogen atom; R 3 represents a hydrogen atom, a halogen atom, or a hydroxy group; R 4 represents a hydrogen atom or a halogen atom; X represents -C(=O)-(CH 2) n -R 5 or -S(=O) 2 -R 6; n is an integer of 0 to 5; R 5 represents a hydrogen atom, -OR 7, -SR 7, -S(=O) 2 -R 7, -C(=O)-OR 7, -N(R 7)R 8, an alkyl group having 1 to 3 carbon atoms, any 1 to 3 hydrogen atoms of which are optionally substituted with a halogen atom(s), or a heteroaryl group, any hydrogen atom(s) of which is/are optionally substituted with an alkyl group(s) having 1 to 3 carbon atoms; R 6 represents an alkyl group having 1 to 5 carbon atoms; R 7 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, any 1 to 3 hydrogen atoms of which are optionally substituted with a halogen atom(s); and R 8 represents a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, an acyl group having 2 to 4 carbon atoms, or an alkylsulfonyl group having 1 to 3 carbon atoms, or a pharmacologically acceptable salt thereof.
Product for an electrical installation, said product comprising a housing having walls defining its inner reception space, characterized in that the electrical installation includes a wired or wireless communication network and at least one item of equipment (6, 7) connected to the latter, in that the inner reception space receives at least one electronic card intended to be connected to said network and to said or to at least one of said item(s) of equipment, and in that the product furthermore comprises an acoustic locating device comprising at least one transducer element capable of emitting an audible acoustic signal when an electric voltage is applied thereto, said element being situated and held fixedly in said space while being connected, for its voltage control, to the electronic card or directly to said network.
Sensor unit comprising: a sensor element which has an optical behaviour which depends on at least one analyte of a sample; a reservoir with an auxiliary medium; characterised in that a membrane is provided which, in a preparatory state of the sensor unit, enables a diffusive contact between the auxiliary medium and the sensor element, and in that the sensor unit can be set to a measuring state, on the one hand by removing the sensor element and on the other hand the membrane and the reservoir from one another. a sensor element which has an optical behaviour which depends on at least one analyte of a sample; a reservoir with an auxiliary medium; characterised in that a membrane is provided which, in a preparatory state of the sensor unit, enables a diffusive contact between the auxiliary medium and the sensor element, and in that the sensor unit can be set to a measuring state, on the one hand by removing the sensor element and on the other hand the membrane and the reservoir from one another.
A method for manufacturing a card comprising a transparent window with a front side and a back side, the method comprising the step of: printing a color picture on the back side of the window, characterised in that the method comprises further the step of: laser engraving a greyscale image matching the color picture on the front side of the window.
A metal closure comprising: a top wall; a skirt extending downwards from a peripheral edge of the top wall, the skirt having a first end attached to the top wall and a second end defined by a lower edge, the lower edge radially defined between an exterior surface and an interior surface; characterised in that it comprises five radially inwardly extending lugs located at positions about the lower edge such that a midpoint of each lug is spaced approximately 72 degrees ± 1 degree from a midpoint of an adjacent lug as measured from a centre of the closure, the interior surface of the lower edge at the positions of the lugs extends radially inwards relative to the interior surface of the lower edge of the skirt adjacent the lugs; wherein an angular distance between a first end and a second end of each lug, as measured from the centre of the closure, is between approximately 35 degrees and 45 degrees; and a thread engagement surface formed on an upper surface of each lug, the thread engagement surface inclined upwards along a radially extending surface extending from the lug first end to the lug second end. a top wall; a skirt extending downwards from a peripheral edge of the top wall, the skirt having a first end attached to the top wall and a second end defined by a lower edge, the lower edge radially defined between an exterior surface and an interior surface; characterised in that it comprises five radially inwardly extending lugs located at positions about the lower edge such that a midpoint of each lug is spaced approximately 72 degrees ± 1 degree from a midpoint of an adjacent lug as measured from a centre of the closure, the interior surface of the lower edge at the positions of the lugs extends radially inwards relative to the interior surface of the lower edge of the skirt adjacent the lugs; wherein an angular distance between a first end and a second end of each lug, as measured from the centre of the closure, is between approximately 35 degrees and 45 degrees; and a thread engagement surface formed on an upper surface of each lug, the thread engagement surface inclined upwards along a radially extending surface extending from the lug first end to the lug second end.
A method of determining amino acid sequences of peptides that bind to an MHC-I or HLA-I complex or an MHC-II or HLA-II complex, comprising: providing an obtained sample comprising an MHC-I or HLA-I complex or an MHC-II or HLA-II complex and isolating unlabeled peptides from the MHC-I or HLA-I complex or the MHC-II or HLA-II complex to produce a sample comprising unlabeled isolated peptides; adding one or more labeled peptides to the sample to form a single mixed sample comprising the labeled peptides and the unlabeled isolated peptides; analyzing the single mixed sample with an LC-MS/MS system to produce survey mass spectrometry scans of the sample; integrating into the LC-MS/MS system a target label filter based on the survey mass spectrometry scans to monitor a list of the one or more labeled peptides, wherein the filter comprises an algorithm that increases scan duration when the labeled peptides are detected, thereby creating an integrated LC-MS/MS system; analyzing the single mixed sample continuously with the integrated LC-MS/MS system, wherein detection of the one or more labeled peptides triggers the LC-MS/MS system to scan unlabeled isolated peptides until the integrated LC-MS/MS no longer detects the one or more labeled peptides; wherein the integrated LC-MS/MS system alternates between obtaining survey scans and scans of the one or more labeled peptides for the detection of endogenous peptides having the identical amino acid sequence of the one or more labeled peptides, respectively, and determining the amino acid sequence of the unlabeled isolated peptides scanned by the integrated LC-MS/MS system. providing an obtained sample comprising an MHC-I or HLA-I complex or an MHC-II or HLA-II complex and isolating unlabeled peptides from the MHC-I or HLA-I complex or the MHC-II or HLA-II complex to produce a sample comprising unlabeled isolated peptides; adding one or more labeled peptides to the sample to form a single mixed sample comprising the labeled peptides and the unlabeled isolated peptides; analyzing the single mixed sample with an LC-MS/MS system to produce survey mass spectrometry scans of the sample; integrating into the LC-MS/MS system a target label filter based on the survey mass spectrometry scans to monitor a list of the one or more labeled peptides, wherein the filter comprises an algorithm that increases scan duration when the labeled peptides are detected, thereby creating an integrated LC-MS/MS system; analyzing the single mixed sample continuously with the integrated LC-MS/MS system, wherein detection of the one or more labeled peptides triggers the LC-MS/MS system to scan unlabeled isolated peptides until the integrated LC-MS/MS no longer detects the one or more labeled peptides; wherein the integrated LC-MS/MS system alternates between obtaining survey scans and scans of the one or more labeled peptides for the detection of endogenous peptides having the identical amino acid sequence of the one or more labeled peptides, respectively, and determining the amino acid sequence of the unlabeled isolated peptides scanned by the integrated LC-MS/MS system.
A solid oral dosage form comprising a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of hydrochlorothiazide (HCTZ), and c) a hydrophilic filler wherein the hydrophilic filler is present as a mixture of wheat starch and lactose; wherein said solid oral dosage form is made by a process comprising the steps of: i) granulating a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of hydrochlorothiazide (HCTZ), and c) a hydrophilic filler wherein the hydrophilic filler is present as a mixture of wheat starch and lactose, and additives with a granulation liquid; ii) drying a resulting granulate; iii) mixing the dried granulate with outer phase excipients; iv) compressing a resulting mixture to form a solid oral dosage as a core tablet; and v) optionally coating a resulting core tablet to give a film-coated tablet; wherein the preparation of the granular phase in steps (i) and (ii) is performed as two separate phases, one containing the component (a), the other containing the component (b); wherein the phase containing component (a) undergoes organic wet granulation and the phase containing component (b) undergoes aqueous wet granulation; and whereby the two granular phases are combined prior to step (iii); and wherein component (c) is present in the granular phase containing component (b). a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of hydrochlorothiazide (HCTZ), and c) a hydrophilic filler wherein the hydrophilic filler is present as a mixture of wheat starch and lactose; i) granulating a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of hydrochlorothiazide (HCTZ), and c) a hydrophilic filler wherein the hydrophilic filler is present as a mixture of wheat starch and lactose, and additives with a granulation liquid; a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of hydrochlorothiazide (HCTZ), and c) a hydrophilic filler wherein the hydrophilic filler is present as a mixture of wheat starch and lactose, ii) drying a resulting granulate; iii) mixing the dried granulate with outer phase excipients; iv) compressing a resulting mixture to form a solid oral dosage as a core tablet; and v) optionally coating a resulting core tablet to give a film-coated tablet;
A prefabricated monolithic white chamber structure, for the food, electronic, pharmaceutic, hospital, medical, optical industry, comprising one or more shop pre-assembled modules, including all the necessary utility assemblies and adapted to be re-assembled at a use site, each said module comprising a prefabricated pre-insulated floor, perimetrical walls and inner separating walls, doors and windows, an air delivery plenum chamber of a laminar flow type and with a plurality of recovering channels, and an air processing unit arranged on a top of the white chamber, in a fitting or auxiliary equipment space, said prefabricated pre-insulated floor being made of a stainless steel sheet metal material, reinforced by steel section members optionally resin coated, said structure comprises a plurality of steel frames, all said steel frames being sprayed by a plurality of high density polyurethane layers forming steam barriers, said walls comprising a plurality of perimetrical panels forming inner dividing walls and a ceiling of said white chamber; said panels being of a double-skin or coating sandwich type with a white glass-resin inner and outer finishing; each said panel having an inner part of a polystyrene material, thereby the whole structure being periodically completely sanitisable and washable, said structure being characterized in that it comprises a plurality of single-wing doors of a plastic material with an inspection window, single-wing doors of a plastic material without inspection window, and perimetrical stainless steel windows and cove mouldings built-in in the structure floor; said air processing unit comprising an air processing construction including a plurality of polyester panels having rounded corner portions and being designed for allowing all the inner elements to be washed; said panels being made of a polyester material with an associated high thickness thermoacoustic insulating arrangement; the inner fittings, such as fans, thermoigrometric processing batteries and filters, being mounted and firmly fixed to a stainless steel frame; said stainless steel frame being anchored to a galvanized steel framework, outside of the air processing unit, and being raised from the floor plane; said unit comprising resin processed surfaces for providing a sealed connection and for insulating the air processing unit; said air processing unit further comprising air processing unit doors, at each section, for servicing and inspecting the filters and movable parts; said doors comprising fixed gaskets of a closed cell type with related progressive clamping closing handles; the fan chamber access door including a protection micro-switch assembly for switching the fans to an off condition.
A method for decoding an encoded higher-order Ambisonics, HOA, representation of a 2- or 3-dimensional sound field, the decoding method comprising: - receiving a bit stream containing the encoded HOA representation, including 0 encoded spatial domain signals; - perceptual decoding each one of the encoded spatial domain signals into a corresponding decoded spatial domain signal, wherein the decoded spatial domain signals represent a regular distribution of reference points on a sphere; - transforming the decoded spatial domain signals for a frame into 0 HOA coefficients of the frame; and individually decoding discrete sound objects. - receiving a bit stream containing the encoded HOA representation, including 0 encoded spatial domain signals; - perceptual decoding each one of the encoded spatial domain signals into a corresponding decoded spatial domain signal, wherein the decoded spatial domain signals represent a regular distribution of reference points on a sphere; - transforming the decoded spatial domain signals for a frame into 0 HOA coefficients of the frame; and
A hydroxamic acid derivative represented by the following formula: wherein, R 1 and R 2 are an alkyl group having from 1 to 10 carbon atoms; R 3 is - n -, wherein n = 0 or 1; and R 4 is a hydrogen atom or methyl. R 1 and R 2 are an alkyl group having from 1 to 10 carbon atoms; R 3 is - n -, wherein n = 0 or 1; and R 4 is a hydrogen atom or methyl.
A silicone composition, comprising: an epoxy-functional organopolysiloxane resin having the average unit formula (R 1 R 2 R 3 SiO 1/2) a (R 4 R 5 SiO 2/2) b (R 6 SiO 3/2) c (SiO 4/2) d wherein R 1, R 2, R 3, R 4, R 5, and R 6 are organic groups independently selected from C 1-6 monovalent aliphatic hydrocarbon groups, C 6-10 monovalent aromatic hydrocarbon groups, and monovalent epoxy-substituted organic groups, 0≤a<0.4, 0<b<0.5, 0<c<1, 0≤d<0.4, 0.1≤b/c≤0.3, a+b+c+d=1, the resin has a number-average molecular weight of at least 2000, at least 15 mol% of the organic groups are C 6 to C 10 monovalent aromatic hydrocarbon groups, and 2 to 50 mol% of siloxane units have epoxy-substituted organic groups; an epoxy-functional organosiloxane oligomer having an average of at least two epoxy-substituted organic groups per molecule and a molecular weight not greater than 1500; a cationic photoinitiator; and optionally, an organic solvent. an epoxy-functional organopolysiloxane resin having the average unit formula (R 1 R 2 R 3 SiO 1/2) a (R 4 R 5 SiO 2/2) b (R 6 SiO 3/2) c (SiO 4/2) d wherein R 1, R 2, R 3, R 4, R 5, and R 6 are organic groups independently selected from C 1-6 monovalent aliphatic hydrocarbon groups, C 6-10 monovalent aromatic hydrocarbon groups, and monovalent epoxy-substituted organic groups, 0≤a<0.4, 0<b<0.5, 0<c<1, 0≤d<0.4, 0.1≤b/c≤0.3, a+b+c+d=1, the resin has a number-average molecular weight of at least 2000, at least 15 mol% of the organic groups are C 6 to C 10 monovalent aromatic hydrocarbon groups, and 2 to 50 mol% of siloxane units have epoxy-substituted organic groups; an epoxy-functional organosiloxane oligomer having an average of at least two epoxy-substituted organic groups per molecule and a molecular weight not greater than 1500; a cationic photoinitiator; and optionally, an organic solvent.
A soft magnetic alloy having a composition of the following Chemical Formula: Fe 100-a-b Si a Cr b where a+b is in the range of 10.5 to 18 at%, characterized in that, a is in the range of 1 to 5 at% and b is in the range of 11 to 17 at%.
Method for the time-differentiated detection of a spectrum of a test object, comprising the steps: - providing a first conversion dye, which is configured to convert light in a first spectral distribution in the visible range into light of a second spectral distribution in the infrared range; - exciting the first conversion dye with a light pulse in the range of the first spectral distribution during a first time period (T 2); - registering during a first time interval (T 2) a light fraction, reflected or transmitted by the test object, in the range of the first spectral distribution; - registering a light fraction of the converted light, reflected or transmitted by the test object, during a second time period (T 3) after the first time period (T 2); wherein the first time interval (T 1) is selected so that the first time interval (T 2) lies substantially inside a luminescence lifetime for the first conversion dye in the first time period (T 2). - providing a first conversion dye, which is configured to convert light in a first spectral distribution in the visible range into light of a second spectral distribution in the infrared range; - exciting the first conversion dye with a light pulse in the range of the first spectral distribution during a first time period (T 2); - registering during a first time interval (T 2) a light fraction, reflected or transmitted by the test object, in the range of the first spectral distribution; - registering a light fraction of the converted light, reflected or transmitted by the test object, during a second time period (T 3) after the first time period (T 2);